The Enterprise Value as of November 2024 (TTM) for Haemonetics Corporation (HAE) is 5.37B

According to Haemonetics Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 5.37B. This represents a change of 6.75% compared to the average of 5.03B of the last 4 quarters.

Haemonetics Corporation (HAE) Historical Enterprise Value (quarterly & annually)

How has HAE Enterprise Value performed in the past?

The mean historical Enterprise Value of Haemonetics Corporation over the last ten years is 4.05B. The current 5.37B Enterprise Value has changed 13.17% with respect to the historical average. Over the past ten years (40 quarters), HAE's Enterprise Value was at its highest in in the September 2019 quarter at 6.57B. The Enterprise Value was at its lowest in in the July 2016 quarter at 1.81B.

Haemonetics Corporation (HAE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Haemonetics Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Haemonetics Corporation (HAE) Average Enterprise Value

How has HAE Enterprise Value performed in the past?

The current Enterprise Value of Haemonetics Corporation (HAE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Haemonetics Corporation (HAE) Enterprise Value vs. Peers

How is HAE’s Enterprise Value compared to its peers?

Haemonetics Corporation’s Enterprise Value is less than Merit Medical Systems, Inc. (6.36B), greater than AngioDynamics, Inc. (233.83M), less than AptarGroup, Inc. (12.26B), greater than Envista Holdings Corporation (4.37B), less than Hologic, Inc. (18.72B), greater than ICU Medical, Inc. (5.14B), less than The Cooper Companies, Inc. (22.96B), less than Teleflex Incorporated (10.49B), less than West Pharmaceutical Services, Inc. (22.94B), less than Alcon Inc. (41.47B), less than ResMed Inc. (37.12B), greater than Akoya Biosciences, Inc. (181.40M), greater than AtriCure, Inc. (1.69B), greater than Atrion Corporation (797.97M),

Build a custom stock screener for Haemonetics Corporation (HAE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Haemonetics Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Haemonetics Corporation (HAE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Haemonetics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.